Literature DB >> 19202045

Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge.

Mariam Hassan1, Maureen J Lage.   

Abstract

PURPOSE: The relationship between nonadherence to antipsychotic medication after hospital discharge and risk of rehospitalization in patients who were previously hospitalized for treatment of bipolar disorder was studied.
METHODS: Administrative claims data from 2000 through 2006 were obtained from commercial insurance plans. Patients age 18-64 years who were discharged from a hospital with a diagnosis of bipolar disorder and given a prescription for an antipsychotic 0-14 days after discharge comprised the study sample. Adherence to antipsychotic medication was determined by measuring the number of unique days during which medication was supplied during the treatment period, a calculation known as the medication possession ratio (MPR). Rehospitalization was considered to be an indicator of relapse. A multivariate, stepwise logistic regression, which controlled for patient characteristics, type of bipolar disorder, general health status, and comorbid conditions, was used to assess the relationship between medication non-adherence and rehospitalization.
RESULTS: A total of 1973 individuals were included in the analyses. The mean +/- S.D. MPR for this patient population was 0.46 +/- 0.32. Patients whose MPR was 0.75 or greater had a lower risk of all-cause rehospitalization (odds ratio [OR], 0.730; 95% confidence interval [CI], 0.580-0.919) and a lower risk of a mental-health-related rehospitalization (OR, 0.759; 95% CI, 0.603-0.955). As medication adherence increased above the MPR of 0.75, the risk of rehospitalization significantly decreased.
CONCLUSION: Among patients who were previously hospitalized for treatment of bipolar disorder, those who were adherent to their antipsychotic medication at least 75% of the time had lower risks of all-cause rehospitalization and mental-health-related rehospitalization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19202045     DOI: 10.2146/ajhp080374

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  21 in total

Review 1.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 2.  Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.

Authors:  Michael W Jann
Journal:  Am Health Drug Benefits       Date:  2014-12

3.  Predictors of medication adherence postdischarge: the impact of patient age, insurance status, and prior adherence.

Authors:  Marya J Cohen; Shimon Shaykevich; Courtney Cawthon; Sunil Kripalani; Michael K Paasche-Orlow; Jeffrey L Schnipper
Journal:  J Hosp Med       Date:  2012-04-02       Impact factor: 2.960

4.  State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder.

Authors:  Jonathan D Brown; Allison Barrett; Kerianne Hourihan; Emily Caffery; Henry T Ireys
Journal:  Community Ment Health J       Date:  2015-03-19

5.  Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis.

Authors:  Martha Sajatovic; Daisy Ng-Mak; Caitlyn T Solem; Fang-Ju Lin; Krithika Rajagopalan; Antony Loebel
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-13

6.  Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).

Authors:  Alessandra Barraco; Andrea Rossi; Giuseppe Nicolò
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 7.  Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2012-07-01       Impact factor: 4.981

8.  Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder.

Authors:  Louisa G Sylvia; Aleena Hay; Michael J Ostacher; David J Miklowitz; Andrew A Nierenberg; Michael E Thase; Gary S Sachs; Thilo Deckersbach; Roy H Perlis
Journal:  J Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.153

9.  Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.

Authors:  Wayne Macfadden; Caleb M Adler; Ibrahim Turkoz; John T Haskins; Norris Turner; Larry Alphs
Journal:  BMC Psychiatry       Date:  2011-10-28       Impact factor: 3.630

10.  Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.

Authors:  Ariel Berger; John Edelsberg; Kafi N Sanders; Jose Ma J Alvir; Marko A Mychaskiw; Gerry Oster
Journal:  BMC Psychiatry       Date:  2012-08-02       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.